CAPITAL STOCK | NOTE H — CAPITAL STOCK Cash dividends Dividends were declared in 2017 and 2016 as follows: Dividend per share Date declared Date of record Payment date $0.0425 March 3, 2016 May 2, 2016 May 16, 2016 $0.0425 June 9, 2016 August 1, 2016 August 15, 2016 $0.0425 August 4, 2016 November 1, 2016 November 15, 2016 $0.0425 November 3, 2016 February 1, 2017 February 15, 2017 $0.0425 March 8, 2017 May 1, 2017 May 15, 2017 $0.0425 June 22, 2017 August 1, 2017 August 15, 2017 $0.0425 August 4, 2017 November 1, 2017 November 15, 2017 $0.0425 November 7, 2017 February 1, 2018 February 15, 2018 On March 8, 2018, the Board of Directors declared a quarterly dividend of $0.0425 per share payable on May 15, 2018 to shareholders of record on May 1, 2018. Stock repurchase program On April 30, 2013, Lifetime’s Board of Directors authorized the repurchase of up to $10.0 million of the Company’s common stock. The repurchase authorization permits the Company to effect repurchases from time to time through open market purchases and privately negotiated transactions. No shares were repurchased during the years ended December 31, 2017, 2016 and 2015. Preferred stock The Company is authorized to issue 100 shares of Series A Preferred Stock and 2,000,000 shares of Series B Preferred Stock, none of which has been issued or is outstanding at December 31, 2017. Long-term incentive plan The Company’s Amended and Restated 2000 Long-Term Incentive Plan (the “Plan”) provides for the granting of awards of up to 5,287,500 shares of common stock. These shares of the Company’s common stock are available for grants to directors, officers, employees, consultants and service providers and affiliates in the form of stock options or other equity-based awards. The Plan authorizes the Board of Directors of the Company, or a duly appointed committee thereof, to issue incentive stock options, non-qualified Stock options A summary of the Company’s stock option activity and related information for the three years ended December 31, 2017, is as follows: Options Weighted- Weighted- Aggregate Options outstanding at December 31, 2014 2,326,627 $ 14.19 Grants 89,600 13.99 Exercises (110,375 ) 8.84 Cancellations (37,750 ) 15.57 Expirations (25,900 ) 26.60 Options outstanding at December 31, 2015 2,242,202 14.28 Grants 66,850 15.44 Exercises (272,325 ) 9.01 Cancellations (30,750 ) 15.39 Expirations (230,577 ) 27.16 Options outstanding at December 31, 2016 1,775,400 13.44 Grants 125,750 17.38 Exercises (300,000 ) 11.34 Cancellations (45,700 ) 16.40 Expirations (99,250 ) 20.40 Options outstanding at December 31, 2017 1,456,200 13.64 4.6 $ 5,019,000 Options exercisable at December 31, 2017 1,250,673 $ 13.05 4.0 $ 4,923,000 The aggregate intrinsic value in the table above represents the total pre-tax in-the-money in-the-money The total intrinsic values of those stock options that were exercised in the years ended December 31, 2017, 2016 and 2015 were $2,071,000, $1,848,000 and $639,000, respectively. The intrinsic value of a stock option that is exercised is calculated at the date of exercise. Total unrecognized stock option compensation expense at December 31, 2017, before the effect of income taxes, was $1.0 million and is expected to be recognized over a weighted-average period of 2.1 years. The Company values stock options using the Black-Scholes option valuation model. The Black-Scholes option valuation model, as well as other available models, was developed for use in estimating the fair value of traded options, which have no vesting restrictions and are fully transferable. The Black-Scholes option valuation model requires the input of highly subjective assumptions including the expected stock price volatility and risk-free interest rate. Because the Company’s stock options have characteristics significantly different from those of traded options, changes in the subjective input assumptions can materially affect the fair value estimates of the Company’s stock options. The weighted-average per share grant date fair value of stock options granted during the years ended December 31, 2017, 2016, and 2015 was $6.37, $5.43 and $4.68, respectively. The fair values for these stock options were estimated at the dates of grant using the following weighted-average assumptions: 2017 2016 2015 Historical volatility 39 % 39 % 39 % Expected term (years) 6.0 6.0 5.2 Risk-free interest rate 1.97 % 1.37 % 1.67 % Expected dividend yield 0.98 % 1.10 % 1.18 % Restricted Stock A summary of the Company’s restricted stock activity and related information for the three years ended December 31, 2017 is as follows: Restricted Weighted- Non-vested 26,511 $ 15.86 Grants 100,073 14.78 Vested (24,649 ) 15.97 Cancellations (500 ) 14.84 Non-vested 101,435 14.77 Grants 109,170 15.64 Vested (46,306 ) 14.79 Cancellations (2,475 ) 14.93 Non-vested 161,824 15.35 Grants 133,352 18.32 Vested (69,795 ) 15.39 Cancellations (6,064 ) 16.07 Non-vested 219,317 $ 17.12 Total unrecognized compensation expense remaining $ 2,932,000 Weighted-average years expected to be recognized over 2.6 The total fair value of restricted stock that vested during the year ended December 31, 2017 was $1.3 million. Performance shares Each performance award represents the right to receive up to 150% of the target number of shares of common stock. The number of shares of common stock earned will be determined based on the attainment of specified performance goals at the end of the performance period, as determined by the Compensation Committee of the Board of Directors. The shares are subject to the terms and conditions of the Plan. A summary of the Company’s performance-based award activity and related information for the three years ended December 31, 2017 is as follows: Performance- awards (1) Weighted- Non-vested — $ — Grants 66,650 14.84 Cancellations (500 ) 14.84 Non-vested 66,150 14.84 Grants 82,000 15.69 Cancellations (2,188 ) 14.94 Non-vested 145,962 15.32 Grants 87,000 18.45 Cancellations (4,070 ) 16.52 Non-vested 228,892 $ 16.49 Total unrecognized compensation expense remaining $ 1,727,000 Weighted-average years expected to be recognized over 1.7 (1) Represents the target number of shares to be issued for each performance-based award. On March 7, 2018, the Compensation Committee of the Board of Directors determined the performance goals set forth in the performance-based awards granted in 2015 were attained and 58,888 shares vested. The Company recognized total stock compensation expense of $3.4 million for the year ended December 31, 2017, of which $1.1 million represents stock option compensation expense and $2.3 million represents restricted stock and performance based compensation expense. The Company recognized total stock compensation expense of $2.9 million for the year ended December 31, 2016, of which $1.4 million represents stock option compensation expense, $1.5 million represents restricted stock, including restricted stock granted to directors and performance based compensation expense, and $32,000 represents stock awards. The Company recognized total stock compensation expense of $5.3 million for the year ended December 31, 2015, of which $2.2 million represents stock option compensation expense, $0.8 million represents restricted stock including restricted stock granted to directors and performance based compensation expense, and $2.2 million represents stock awards. |